Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Excellent Buy Price at 0.18 CAD
View:
Post by DavidKingCanada on Sep 19, 2021 9:51am

Excellent Buy Price at 0.18 CAD

Get in while it's at a very attractive price! For the impatient wait until it reaches mid to high 20's and Sell. For those that have no need to sell and have patience, just wait 2-5 Years for PMN to become known outside of Cambride and Vancouver.
Comment by JackRedwood on Sep 19, 2021 9:53am
I dropped $10,000 when Biogen's aducanumab was approved. As of now I am down more than a quarter. Ah well, I'll wait, but not 5 years! 
Comment by Speyeder999 on Sep 20, 2021 8:40am
I don't think anyone here feels like waiting around for another five years for things to start happening,  but it may just be the natural process of developing a drug (now that it's actually set in motion). The problem with waiting 5 years in the meantime is that new scientific discoveries (see link) won't stop and might make PMN310 obsolete https://newatlas.com/science ...more  
Comment by JackRedwood on Sep 20, 2021 9:35am
Thats what I am worried about is if the timeline is 5 Years there will definitely be other Drugs available especially since Aducanumab was approved. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities